Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Beth

Outbound tourism from Poland to recover to pre-pandemic levels by 2024 as COVID-19 travel restrictions are eased, says GlobalData

Weakened traveler confidence, combined with strict COVID-19 measures, saw Poland’s outbound tourism numbers shrink to a fraction of what they were in 2019, says GlobalData. Figures from the leading data and analytics company reveal that outbound tourism from Poland declined by 62.7% year-on-year (YoY) from 2019 to 2020, to just 6.8 million international departures. However, […]
Read more

Time-saving ready meals that retain value positioning may see an uptick in demand amid cost of living crisis, says GlobalData

A key factor driving the cost of living crisis around the world is the unprecedented rise in energy costs, says GlobalData. The leading data and analytics company notes that as financial pressures worsen, time-saving ready meals that limit meal preparation and cooking times while retaining value positioning may see an uptick in demand. The global […]
Read more

Meta’s sentiment down 5% QoQ in Q2 2022 as hiring and cost reduction are key topics of discussion during earning calls, finds GlobalData

Meta Platforms’ (Meta) sentiment declined 5% in Q2 2022 over Q1 2022, according to GlobalData’s Company Filing Analytics database. The leading data and analytics company found that sentiment for Meta fell due to negativity around privacy changes, hiring and costs. ‘Headwind’ as a keyword appeared more prominently on Meta’s two earnings call transcripts in Q1 and […]
Read more

Rafael’s Aerospike missile will greatly benefit special operations forces requiring close-air support, says GlobalData

Following the news that Israeli firm Rafael Advanced Defense Systems has unveiled its new Aerospike next generation air-to-surface missile (ASM) at the Special Operations Forces Industry Conference (SOFIC) 2022; Tristan Sauer, Land Analyst at GlobalData, a leading data and analytics company, offers his view: “As the latest product in the Spike missile family, the Aerospike […]
Read more

Global risk rises in Q1 2022 with fears of stagflation amid Russia-Ukraine conflict, says GlobalData

Russia’s invasion of Ukraine is the third asymmetric global shock following the 2008 financial crisis and the COVID-19 pandemic, which may shrivel the global economy’s recovery path, says GlobalData. The leading data and analytics company notes that supply chain disruption, rising price levels and an uneven vaccination drive were the major risk factors globally in […]
Read more

UCB is well-positioned to become a key player in the myasthenia gravis market with zilucoplan and rozanolixizumab, says GlobalData

Positive Phase III trial results from UCB’s two clinical trials in its generalized myasthenia gravis (gMG) program will enable it to become a key future player in the MG market, with both zilucoplan and rozanolixizumab expected to enter the market next year, says GlobalData, a leading data and analytics company. Philippa Salter, Neurology Analyst at […]
Read more

Complement inhibition is becoming a key neuroimmunology mechanism of action, with pipeline agents spanning numerous indications, says GlobalData

The complement cascade, an arm of the innate immune system consisting of a collection of small proteins with various functions in targeting pathogens, has been implicated in the pathology of a number of different neurological diseases, from autoimmune diseases like myasthenia gravis (MG) to neurodegenerative diseases like amyotrophic lateral sclerosis (ALS), says GlobalData. The leading […]
Read more

Leading oil and gas companies are tapping into digital technologies to improve productivity and profitability, says GlobalData

Digitalization, which involves the adoption of digital technologies such as artificial intelligence (AI), big data, cloud computing, cybersecurity, the Internet of Things (IoT), and robotics in day-to-day oil and gas operations, is enabling the industry to improve productivity and profitability by streamlining operations and cutting costs, says GlobalData, a leading data and analytics company. According […]
Read more

Osteoarthritis pipeline shifting from analgesics to disease-modifying treatments as conventional analgesics offer inadequate pain relief, says GlobalData

The current osteoarthritis (OA) market has previously suffered from a lack of effective analgesics and disease-modifying osteoarthritis drugs (DMOADs) partially due to the complex pathophysiology of OA and the lack of appropriate outcome measures for progression of joint damage, says GlobalData. However, the leading data and analytics company notes that drugs that are currently under […]
Read more

McDonald’s plan to “de-arch” its operations in Russia could see it expand its presence in Asia and Europe, says GlobalData

Following McDonald’s announcement that it will end all of its operations and branding in Russia; Ramsey Baghdadi, Consumer Analyst at GlobalData, a leading data and analytics company, offers his view: “The fast-food giant has clearly recognised the impact that continued affiliations with Russia could have on the company. With 72%* of consumer purchases globally driven […]
Read more

Neuroimmunology drug development has exploded over the last decade, growing into a dynamic, high-value space, says GlobalData

Over the last decade, the role of the immune system in the etiology and pathophysiology of neurological diseases has steadily gained clarity, says GlobalData. The leading data and analytics company notes that the development of neuroimmunology drugs* has exploded as a result, with the top 20 neuroimmunology products being worth $20.1 billion in 2020 and […]
Read more

Cryptocurrency volatility shows no signs of abating and will continue to track trends seen in traditional markets, says GlobalData

Following the recent news of continued cryptocurrency volatility following the collapse of stablecoin TerraUSD; Dr Lil Read, Senior Analyst in the Thematic Intelligence Team at GlobalData, a leading data and analytics company, comments: “Many crypto investors view the fact that they are not linked to the value of traditional assets, such as gold, shares in […]
Read more

Mavacamten estimated sales just shy of $1 billion if approved for common cardiomyopathy subtype, says GlobalData

Bristol Myers Squibb’s mavacamten will stand rather unchallenged in the hypertrophic cardiomyopathy (HCM) market, achieving around $958 million in sales by 2025, according to GlobalData, a leading data and analytics company. Sarah Bundra, Pharmaceutical Analyst at GlobalData, comments: “Mavacamten will be the first drug to specifically target obstructive HCM, which is a common form of cardiomyopathy. […]
Read more

Integration between 8×8’s ‘Work’ and Genesys’ ‘Cloud CX’ highlights that companies can cooperate to provide a better platform for users, says GlobalData

Contact centers have fundamentally changed since the onset of the COVID-19 pandemic as customers shifted to remote engagement and companies relied on contact centers to manage their customer experience, says GlobalData, a leading data and analytics company. The recent integration between 8×8’s ‘Work’ Unified Communications as a Service (UCaaS) offer and the ‘Cloud CX’ Contact […]
Read more

Chelsea’s new $20 million-a-year sleeve partnership highlights the disruptive nature of cryptocurrency in sports, says GlobalData

Following today’s news (Thursday 12th May) that WhaleFin, a digital asset platform owned by Singapore-based Amber Group, has signed a new $20 million-a-year shirt deal with Chelsea FC; Conrad Wiacek, Head of Sport Analysis at GlobalData, a leading data and analytics company, offers his view: “The new deal between Chelsea and WhaleFin highlights the fact […]
Read more
1 … 15 16 17 18 19 … 93